Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biotechnol ; 101(3): 229-39, 2003 Mar 20.
Article in English | MEDLINE | ID: mdl-12615392

ABSTRACT

The large-scale production of recombinant biotherapeutics, particularly recombinant proteins, provides significant process and regulatory challenges to the biotechnology industry in order to meet the regulatory agencies stringent requirements in a cost-effective manner. Host cell derived nucleic acid causes problems from both a process and a regulatory perspective, as high molecular weight chromosomal DNA is responsible both for the viscosity of cell lysates, and it is a source of heterologous DNA sequences whose inclusion in the final product must be prevented. We have constructed a modified Escherichia coli JM107 expression host (JMN), containing a staphylococcal nuclease expression cassette, integrated into the host chromosome at the dif locus. The nuclease is expressed as a fusion to the ompA signal peptide, and is translocated to the periplasm of the cell, protecting the cytoplasmic nucleic acid from any toxic activity. The nuclease is released during cell lysis, where it subsequently acts to hydrolyse host nucleic acid present in the lysate. Results with this strain show that sufficient levels of nuclease activity are produced to completely auto-hydrolyse the host's chromosomal DNA to a size non-visible on 1% agarose gel, generating a markedly lower lysate viscosity. This provides a suitable methodology to remove heterologous DNA sequences early in the product stream and decrease lysate viscosity, improving the efficiency of downstream processing and product yield, whilst avoiding the addition of exogenous nuclease and its prohibitive costs at large-scale.


Subject(s)
Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression Regulation , Micrococcal Nuclease/biosynthesis , Transfection/methods , Base Sequence , Cloning, Molecular , DNA, Bacterial/genetics , DNA, Bacterial/metabolism , Hydrolysis , Micrococcal Nuclease/genetics , Micrococcal Nuclease/metabolism , Molecular Sequence Data , Recombinant Fusion Proteins/biosynthesis , Staphylococcus aureus/enzymology , Staphylococcus aureus/genetics
2.
Nucleic Acids Res ; 30(4): 1046-55, 2002 Feb 15.
Article in English | MEDLINE | ID: mdl-11842117

ABSTRACT

Active partitioning of low-copy number plasmids requires two proteins belonging to the ParA and ParB families and a cis-acting site which ParB acts upon. Active separation of clusters of plasmid molecules to the defined locations in the cell before cell division ensures stable inheritance of the plasmids. The central control operon of IncP-1 plasmids codes for regulatory proteins involved in the global transcriptional control of operons for vegetative replication, stable maintenance and conjugative transfer. Two of these proteins, IncC and KorB, also play a role in active partitioning, as the ParA and ParB homologues, respectively. Here we describe mapping the regions in KorB responsible for four of its different functions: dimerisation, DNA binding, repression of transcription and interaction with IncC. For DNA binding, amino acids E151 to T218 are essential, while repression depends not only on DNA binding but, additionally, on the adjacent region amino acids T218 to R255. The C-terminus of KorB is the main dimerisation domain but a secondary oligomerisation region is located centrally in the region from amino acid I174 to T218. Using three different methods (potentiation of transcriptional repression, potentiation of DNA binding and activation in the yeast two-hybrid system) we identify this region as also responsible for interactions with IncC. This IncC-KorB contact differs in location from the ParA-ParB/SopA-SopB interactions in P1/F but is similar to these systems in lying close to a masked oligomerisation determinant.


Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/physiology , Plasmids , Amino Acid Sequence , Bacterial Proteins/genetics , Cross-Linking Reagents/chemistry , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Dimerization , Glutaral/chemistry , Molecular Sequence Data , Protein Structure, Tertiary , Repressor Proteins/genetics , Repressor Proteins/physiology , Sequence Deletion , Sequence Homology, Amino Acid , Two-Hybrid System Techniques
3.
J Biotechnol ; 85(3): 297-304, 2001 Feb 23.
Article in English | MEDLINE | ID: mdl-11173096

ABSTRACT

Regulatory agencies have stringent requirements for the large-scale production of biotherapeutics. One of the difficulties associated with the manufacture of plasmid DNA for gene therapy is the removal of the host cell-related impurity RNA following cell lysis. We have constructed a modified Escherichia coli JM107 plasmid host (JMRNaseA), containing a bovine pancreatic ribonuclease (RNaseA) expression cassette, integrated into the host chromosome at the dif locus. The expressed RNaseA is translocated to the periplasm of the cell, and is released during primary plasmid extraction by alkaline lysis. The RNaseA protein is stable throughout incubation at high pH ( approximately 12-12.5), and subsequently acts to hydrolyse host cell RNA present in the neutralised solution following alkaline lysis. Results with this strain harbouring pUC18, and a 2.4 kb pUC18DeltalacO, show that sufficient levels of ribonuclease (RNase) activity are produced to hydrolyse the bulk of the host RNA. This provides a suitable methodology for the removal of RNA, whilst avoiding the addition of exogenous animal sourced RNase and its associated regulatory requirements.


Subject(s)
Escherichia coli/enzymology , Escherichia coli/genetics , Plasmids/isolation & purification , Ribonuclease, Pancreatic/genetics , Animals , Biotechnology , Cattle , Cell Division , DNA, Bacterial/isolation & purification , DNA, Recombinant/genetics , DNA, Recombinant/isolation & purification , Drug Contamination , Escherichia coli/chemistry , Gene Expression , Genetic Therapy , Plasmids/genetics , RNA, Bacterial/isolation & purification , Ribonuclease, Pancreatic/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...